Effect of a Home-Based Wearable Continuous ECG Monitoring Patch on Detection of Undiagnosed Atrial Fibrillation The mSToPS Randomized Clinical TrialJAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATIONIF552018-07-10328OAAI
NOAC monitoring, reversal agents, and post-approval safety and effectiveness evaluation: A cardiac safety research consortium think tankAMERICAN HEART JOURNALIF3.52016-07-0130PREAI
Rationale and design of a home-based trial using wearable sensors to detect asymptomatic atrial fibrillation in a targeted population: The mHealth Screening To Prevent Strokes (mSToPS) trialAMERICAN HEART JOURNALIF3.52016-05-0146OAAI
Novel oral anticoagulants and reversal agents: Considerations for clinical developmentAMERICAN HEART JOURNALIF3.52015-06-0162PREAI
Effects of JNJ-38431055, a novel GPR119 receptor agonist, in randomized, double-blind, placebo-controlled studies in subjects with type 2 diabetesDIABETES OBESITY & METABOLISMIF5.72012-03-1490PREAI
Pharmacokinetics, Pharmacodynamics, Safety, and Tolerability of JNJ-38431055, a Novel GPR119 Receptor Agonist and Potential Antidiabetes Agent, in Healthy Male SubjectsCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52011-10-0541PREAI
Hemostatic effect of activated factor VII without promotion of thrombus growth in melagatran-anticoagulated primatesTHROMBOSIS RESEARCHIF3.42007-01-0117PREAI
The pharmacokinetics and pharmacodynamics of the oral direct thrombin inhibitor ximelagatran when administered with azithromycin and cefuroximeCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52005-02-011PREAI
No effect of amoxicillin, doxycycline, and ciprofloxacin on the pharmacokinetics and pharmacodynamics of ximelagatran.CLINICAL PHARMACOLOGY & THERAPEUTICSIF5.52005-02-011PREAI
A review of the effects of the oral direct thrombin inhibitor ximelagatran on coagulation assaysTHROMBOSIS RESEARCHIF3.42005-01-0129PREAI
The inhibitory effect of melagatran, the active form of the oral direct thrombin inhibitor ximelagatran, compared with enoxaparin and r-hirudin on ex vivo thrombin generation in human plasmaTHROMBOSIS RESEARCHIF3.42004-01-0115PREAI
Acute antithrombotic effects of ximelagatran, an oral direct thrombin inhibitor, and r-hirudin in a human ex vivo model of arterial thrombosisJOURNAL OF THROMBOSIS AND HAEMOSTASISIF52003-05-0131OAAI
The role of L-thyroxine and hepatic reductase activity in isoniazid-induced hepatotoxicity in rabbitsPHARMACOLOGICAL RESEARCHIF10.51998-09-019PRE
The effect of omeprazole pretreatment on acetaminophen metabolism in rapid and slow metabolizers of S-mephenytoinCLINICAL PHARMACOLOGY & THERAPEUTICSIF5.51997-07-0160PREAI
Role of hydrazine in the mechanism of isoniazid hepatotoxicity in rabbitsARCHIVES OF TOXICOLOGYIF6.91996-10-1495PREAI